Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000935836-25-000682·AYTU BIOPHARMA, INC
Schedule 13G ownership disclosure
Aytu BioPharma Inc
Common Stock · CUSIP: 054754858
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- LYTTON LAURENCE W
Shares: 1,086,522.00 · Class: 9.99%
- Lytton-Kambara Foundation
Shares: 1,086,522.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000682
- Form type
- SCHEDULE 13G/A
- Filer
- AYTU BIOPHARMA, INC
- CIK
- CIK 1385818
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership